Dietary antioxidant intake and incidence of early age-related maculopathy: The Blue Mountains Eye Study

Ophthalmology

Volumn 109, Issue 12, 2002, Pages 2272-2278

  Flood, Victoria ^a   Smith, Wayne ^b   Wang, Jie Jin ^a   Manzi, Fiona ^a   Webb, Karen ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CRYPTOXANTHIN; LYCOPENE; RETINOL; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; DIETARY INTAKE; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; PRIORITY JOURNAL; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; COHORT STUDIES; DIET; DIET RECORDS; DIETARY SUPPLEMENTS; FEMALE; FOOD HABITS; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEW SOUTH WALES; QUESTIONNAIRES; VITAMINS; ZINC;

EID: 0036897333     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(02)01263-0     Document Type: Article

References (36)

1. , Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
2. Chan CW, Billson FA. Visual disability and major causes of blindness in NSW: A study of people aged 50 and over attending the Royal Blind Society 1984 to 1989. Aust NZ J Ophthalmol 1991;19:321-5.
3. Cooper RL. Blind registrations in Western Australia: A five-year study, Aust NZ J Ophthalmol 1990;18:421-6.
4. Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
5. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983;67:209-13.
6. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
7. Klein R, Klein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
8. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 2001;108:697-704.
9. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials - TAP report 2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Arch Ophthalmol 2001;119:198-207.
10. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in Photodynamic Therapy Report 2. Verteporfin in Photodynamic Therapy Study Group. Am J Ophthalmol 2001;131:541-60.
11. Ham WT Jr, Mueller HA, Sliney DH, Retinal sensitivity to damage for short wavelength light. Nature 1976;260:153-5.
12. Farnsworth CC, Dratz EA, Oxidative damage of retinal rod outer segment membranes and the role of vitamin E. Biochem Biophys Acta 1976;443:556-70.
13. Ham WT Jr, Mueller HA, Ruffolo JJ Jr, et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984;3:165-74.
14. Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp Eye Res 1997;65:57-62.
15. Landrum JT, Bone RA, Kilburn MD. The macular pigment: A possible role in protection from age-related macular degeneration. Adv Pharmacol 1997;38:537-56.
16. Hammond BR Jr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38:1795-801.
17. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 1988;128:700-10.
18. Mares-Perlman JA, Klein R, Klein BEK, et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 1996;114:991-7.
19. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994;272:1413-20.
20. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 1999;106:761-7.
21. VandenLangenberg GM, Mares-Perlman JA, Klein R, et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998;148:204-14.
22. Cho E, Stampfer MJ, Seddon JM, et al. Prospective study of zinc intake and the risk of age-related macular degeneration. Ann Epidemiol 2001;11:328-36,
23. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Age-Related Eye Disease Study Research Group. Arch Ophthalmol 2001; 119:1417-36.
24. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64.
25. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98: 1128-34.
26. Wang JJ, Mitchell P, Smith W, Cumming RG. Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol 1998;82:743-7.
27. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99.
28. Smith W, Mitchell P, Reay EM, et al. Validity and reproducibility of a self-administered food frequency questionnaire in older people. Aust NZ J Public Health 1998;22:456-63.
29. Department of Community Services and Health. NUTTAB 90 Nutrient Data Table for Use in Australia. Canberra: Australian Government Publishing Service, 1990.
30. Chug-Ahuja JK, Holden JM, Forman MR, et al. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc 1993;93:318-23.
31. Willett WC, Stampfer MJ. Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 1986; 124:17-27.
32. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: The Blue Mountains Eye Study. Ophthalmology 2002;109:1092-7.
33. West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994;112:222-7.
34. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr 1999;70:509-16.
35. Brown L, Rimm EB, Seddon JM, et al. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr 1999;70:517-24.
36. Willett WC. Invited commentary: Comparison of food frequency questionnaires. Am J Epidemiol 1998;148:1157-9; discussion 1162-5.